InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,589.81
(
-0.78%
)
US TECH 100
19,713.20
(
-2.01%
)
Dow Jones
39,738.65
(
0.04%
)
Brent Oil
85.21
(
0.19%
)
Bitcoin
57,699.37
(
-0.10%
)

Replies to post #105796 on Anavex Life Sciences Corp (AVXL)

Replies to #105796 on Anavex Life Sciences Corp (AVXL)

seventhwave

05/22/17 12:22 AM

#105798 RE: chrismiss_everyday #105796

Yeah, what they're saying is although the post 52 week phase is being considered a new (back2back / follow-on) trial, it's still a (2nd) P2a. It is not to be confused as a P2/3.